|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 207.77 USD | -0.12% |
|
-2.76% | +13.76% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
Stock exchange
Nasdaq
AXSM 207.77 $
-0.12%
153M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| AXSM | 207.77USD | -0.12% | 153M $ | ||
CBOE
| AXSM | 207.67USD | -0.16% | 3.15M $ | |
|
Tradegate
| 19X | 177.90EUR | -0.17% | 37.54K € | |
|
Boerse Muenchen
| 19X | 178.05EUR | +0.03% | 19.76K € | |
|
Deutsche Boerse AG
| 19X | 176.25EUR | -4.76% | 0 € | |
|
Börse Stuttgart
| 19X | 178.05EUR | +0.42% | 0 € | |
|
Borsa Italiana
| 1AXSM | 180.40EUR | -3.71% | 0 € | |
|
Xetra
| 19X | 179.45EUR | -4.09% | 0 € |
Quotes 5-day view: Axsome Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-08-17 | 2026-08-18 | 2026-08-19 | 2026-08-20 | 2026-08-21 | |
|---|---|---|---|---|---|
| Last | US$216.27 | US$215.69 | US$218.20 | US$208.03 | US$207.77 |
| Volume | 511,870 | 506,353 | 572,114 | 620,926 | 734,950 |
| Change | +1.22% | -0.27% | +1.16% | -4.66% | -0.12% |
| Opening | US$212.01 | US$215.93 | US$218.93 | US$216.50 | US$207.22 |
| High | US$216.96 | US$220.01 | US$222.46 | US$217.85 | US$210.87 |
| Low | US$211.44 | US$214.39 | US$216.73 | US$206.26 | US$206.50 |
Performance
| 1 day | -0.12% | ||
| 1 week | -2.76% | ||
| Current month | -4.69% | ||
| 1 month | -13.29% | ||
| 3 months | -11.95% | ||
| 6 months | +13.09% | ||
| Current year | +13.76% | ||
| 1 year | +75.32% | ||
| 3 years | +173.17% | ||
| 5 years | +863.68% | ||
| 10 years | +2,641.03% |
Volumes
marketsDaily volume
734,950
Estimated daily volume
734,950
Avg. Volume 20 sessions
744,814
Daily volume ratio
0.99
Avg. Volume 20 sessions USD
154,750,004.78
Record volume 1
51,674,500
Record volume 2
25,307,160
Record volume 3
23,596,000
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Market Cap (USD)
10,883,162,555
Net sales (USD)
638,496,000
Number of employees
1,346
Sales / Employee (USD)
474,366
Free-Float
84.69 %
Free-Float capitalization (USD)
9,217,173,977
Average Daily Capital Traded
1.42%
Indicators
Moving average 5 days
213.19
Moving average 20 days
219.46
Moving average 50 days
233.17
Moving average 100 days
220.25
Price spread / (MMA5)
+2.61%
Price spread / (MMA20)
+5.62%
Price spread / (MMA50)
+12.23%
Price spread / (MMA100)
+6.01%
STIM
RSI 9 days
34.55
RSI 14 days
37.52
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | -2.76% | +75.32% | +173.17% | 10.88B | |
| +0.90% | +3.80% | +41.49% | -0.78% | 83.28B | |
| +8.86% | +129.20% | +435.14% | +24.85% | 57.94B | |
| -1.69% | +23.30% | -22.30% | -36.29% | 57.77B | |
| -1.46% | +0.19% | -2.06% | +30.50% | 51.75B | |
| +1.74% | +4.43% | +12.37% | +169.64% | 49.35B | |
| +1.13% | +3.31% | +55.61% | -17.57% | 32.03B | |
| +0.46% | +6.37% | +50.29% | +97.27% | 25.91B | |
| +1.19% | +9.17% | +2.97% | +230.86% | 22.74B | |
| -0.30% | +4.45% | +58.29% | +118.84% | 16.87B | |
| Average | +1.07% | +18.16% | +70.71% | +79.05% | 40.85B | |
| Weighted average by Cap. | +1.39% | +24.24% | +80.38% | +49.75% |
Historical Quotes: Axsome Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
925c300.hglKkxCcx6mFPPpBVxWROa6kW0JOO56za7wLI33DzIc.z1A7o2TZ8fnMbbg4YGbgau2dFBgBfcnYL-s7fCXu9e3LWRnhUenw0NZTqw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 207.77 | 121,715 | 506,638 |
| 15:59:59 | 207.69 | 100 | 384,923 |
| 15:59:59 | 207.70 | 100 | 384,823 |
| 15:59:58 | 207.79 | 100 | 384,723 |
| 15:59:57 | 207.61 | 120 | 384,623 |
| 15:59:56 | 207.66 | 100 | 384,503 |
| 15:59:56 | 207.79 | 100 | 384,403 |
| 15:59:54 | 207.79 | 100 | 384,303 |
| 15:59:54 | 207.85 | 100 | 384,203 |
| 15:59:54 | 207.84 | 100 | 384,103 |
Course Extremes
| 1 week | 206.26 |  | 222.46 |
| 1 month | 206.26 | | 245.5 |
| Current year | 152.28 | | 260.19 |
| 1 year | 112.9 | | 260.19 |
| 3 years | 55.02 | | 260.19 |
| 5 years | 20.63 | | 260.19 |
| 10 years | 1.94 | | 260.19 |
Monthly variations
Annual variations
| 2026 | +13.76% | ||
| 2025 | +115.86% | ||
| 2024 | +6.31% | ||
| 2023 | +3.19% | ||
| 2022 | +104.16% | ||
| 2021 | -53.63% | ||
| 2020 | -21.18% | ||
| 2019 | +3,565.25% | ||
| 2018 | -49.64% | ||
| 2017 | -17.04% | ||
| 2016 | -27.18% | ||
| 2015 | +6.06% |
- Stock Market
- Stocks
- AXSM Stock
- Quotes Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
